Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs lidocaine for postoperative emotional state and early recovery after nasal endoscopic surgery
ChiCTR2200060947Phase 4Not yet recruiting
- Sponsor
- Affiliated Huai'an Hospital of Xuzhou Medical University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and lidocaine in postoperative pain, anxiety disorder, postoperative depression and 1 more (3 arms), sponsored by Affiliated Huai'an Hospital of Xuzhou Medical University. Primary endpoints: Quality of Recovery-40 (QoR-40) survey, Self-Rating Anxiety Scale (SAS) and 1 more. Planned start May 2022; status: not yet recruiting.
02
Drugs
esketaminelidocaine
03
Conditions
postoperative painanxiety disorderpostoperative depressionDelayed postoperative recovery (DPR)
Beyond the preview
Go deeper on ChiCTR2200060947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060947.